Alternative therapies for weight loss In September 2022, the TGA requested healthcare professionals prioritise supplies of semaglutide for patients with type 2 diabetes
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes and Obesity (TRIUMPH-2)
Nat Med 28(10):20832091 Knop FK, Aroda VR, do Vale RD, Holst-Hansen T, Laursen PN, Rosenstock J et al (2023) Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
doi: 10.3390/nu10030349, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 36.Meyburg J, Schulze A, Kohlmueller D, Pschl J, Linderkamp O, Hoffmann GF, et al
Then, I set them up with a personalized lifestyle and wellness plan that aims to tackle the underlying causes of their issue
Why wouldnt you try a lower dose, safer, shorter term to see if it helps kickstart there